FDA delays decision on abuse deterrence data on Endo painkiller
Data could be used to fend off generic competition.
X
FDA delays decision on abuse deterrence data on Endo painkiller
https://pharmaphorum.com/news/fda-delays-decision-on-key-abuse-deterrence-data-on-endo-painkiller/
